| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sodium Chloride Symporters | 10 | 2022 | 13 | 2.620 |
Why?
|
| Kidney Tubules, Distal | 11 | 2022 | 20 | 2.480 |
Why?
|
| Parathyroid Hormone | 4 | 2023 | 218 | 1.490 |
Why?
|
| Calcium | 4 | 2023 | 1156 | 1.360 |
Why?
|
| TRPV Cation Channels | 2 | 2017 | 15 | 1.170 |
Why?
|
| Kidney Calculi | 3 | 2023 | 339 | 1.140 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2011 | 73 | 1.060 |
Why?
|
| Aldosterone | 3 | 2022 | 65 | 0.760 |
Why?
|
| Urine | 2 | 2019 | 90 | 0.730 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2016 | 61 | 0.650 |
Why?
|
| Angiotensin II | 2 | 2016 | 94 | 0.640 |
Why?
|
| Sodium | 6 | 2022 | 341 | 0.640 |
Why?
|
| Diabetes Insipidus | 1 | 2017 | 17 | 0.630 |
Why?
|
| Lithium | 1 | 2017 | 59 | 0.630 |
Why?
|
| Kidney Tubules | 1 | 2017 | 94 | 0.590 |
Why?
|
| Hypercalciuria | 2 | 2023 | 47 | 0.560 |
Why?
|
| Vasopressins | 2 | 2015 | 49 | 0.550 |
Why?
|
| Hyponatremia | 1 | 2015 | 25 | 0.540 |
Why?
|
| Renal Reabsorption | 1 | 2015 | 8 | 0.530 |
Why?
|
| Thiazides | 3 | 2022 | 19 | 0.520 |
Why?
|
| Mice | 19 | 2022 | 11352 | 0.520 |
Why?
|
| Calcium Channels | 1 | 2015 | 182 | 0.490 |
Why?
|
| Aging | 1 | 2019 | 691 | 0.490 |
Why?
|
| Solute Carrier Family 12, Member 3 | 6 | 2017 | 7 | 0.460 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 297 | 0.450 |
Why?
|
| Cell Line | 8 | 2016 | 2468 | 0.440 |
Why?
|
| Signal Transduction | 5 | 2017 | 3241 | 0.430 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2010 | 137 | 0.400 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 115 | 0.390 |
Why?
|
| Animals | 20 | 2022 | 26582 | 0.390 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 192 | 0.380 |
Why?
|
| Receptors, Drug | 1 | 2010 | 54 | 0.370 |
Why?
|
| Hypertension | 4 | 2022 | 1141 | 0.360 |
Why?
|
| Symporters | 1 | 2010 | 107 | 0.350 |
Why?
|
| Endocytosis | 1 | 2010 | 177 | 0.340 |
Why?
|
| Diuretics | 1 | 2009 | 124 | 0.340 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2022 | 12 | 0.330 |
Why?
|
| Casein Kinase I | 1 | 2008 | 2 | 0.330 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 371 | 0.310 |
Why?
|
| Kidney | 4 | 2019 | 1241 | 0.300 |
Why?
|
| Protein Kinase C | 1 | 2007 | 270 | 0.290 |
Why?
|
| Phosphorylation | 4 | 2015 | 1106 | 0.290 |
Why?
|
| Colonic Diseases | 1 | 2016 | 65 | 0.280 |
Why?
|
| Drug Resistance, Multiple | 1 | 2005 | 20 | 0.270 |
Why?
|
| Diterpenes | 1 | 2005 | 20 | 0.270 |
Why?
|
| Health Care Reform | 1 | 2016 | 90 | 0.270 |
Why?
|
| Colectomy | 1 | 2016 | 167 | 0.260 |
Why?
|
| Cells, Cultured | 5 | 2019 | 2818 | 0.250 |
Why?
|
| Renal Dialysis | 1 | 2007 | 355 | 0.240 |
Why?
|
| Sex Factors | 2 | 2019 | 1054 | 0.240 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2005 | 458 | 0.240 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 209 | 0.240 |
Why?
|
| Transcription Factors | 2 | 2008 | 1565 | 0.220 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 1920 | 0.220 |
Why?
|
| Desoxycorticosterone Acetate | 1 | 2022 | 1 | 0.220 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 509 | 0.210 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2005 | 592 | 0.210 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 582 | 0.200 |
Why?
|
| Immediate-Early Proteins | 2 | 2013 | 164 | 0.200 |
Why?
|
| Ion Transport | 2 | 2017 | 81 | 0.190 |
Why?
|
| Magnesium | 2 | 2023 | 177 | 0.180 |
Why?
|
| Male | 10 | 2019 | 40965 | 0.180 |
Why?
|
| Ammonia | 1 | 2019 | 37 | 0.170 |
Why?
|
| Anions | 1 | 2019 | 31 | 0.170 |
Why?
|
| Bicarbonates | 1 | 2019 | 60 | 0.170 |
Why?
|
| Time Factors | 3 | 2015 | 5210 | 0.170 |
Why?
|
| Sulfates | 1 | 2019 | 56 | 0.170 |
Why?
|
| Zinc | 1 | 2019 | 91 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 493 | 0.160 |
Why?
|
| Adipose Tissue, White | 1 | 2017 | 18 | 0.160 |
Why?
|
| Potassium | 1 | 2019 | 281 | 0.160 |
Why?
|
| Glucuronidase | 1 | 2017 | 20 | 0.160 |
Why?
|
| Renin | 1 | 2017 | 79 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 559 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 384 | 0.150 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 191 | 0.150 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 80 | 0.150 |
Why?
|
| Epithelial Sodium Channels | 1 | 2016 | 7 | 0.150 |
Why?
|
| Humans | 12 | 2023 | 86643 | 0.140 |
Why?
|
| Blotting, Western | 2 | 2010 | 782 | 0.140 |
Why?
|
| HeLa Cells | 2 | 2008 | 498 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2019 | 770 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2016 | 101 | 0.130 |
Why?
|
| Postprandial Period | 1 | 2015 | 47 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 122 | 0.130 |
Why?
|
| Fasting | 1 | 2015 | 161 | 0.130 |
Why?
|
| Period Circadian Proteins | 1 | 2014 | 10 | 0.120 |
Why?
|
| Epithelial Cells | 2 | 2017 | 669 | 0.120 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 2 | 2019 | 43 | 0.120 |
Why?
|
| Middle Aged | 4 | 2019 | 25028 | 0.120 |
Why?
|
| Adult | 4 | 2019 | 25648 | 0.120 |
Why?
|
| Blood Pressure | 2 | 2019 | 1143 | 0.120 |
Why?
|
| Ubiquitination | 2 | 2011 | 67 | 0.120 |
Why?
|
| Adrenalectomy | 1 | 2013 | 43 | 0.120 |
Why?
|
| Female | 5 | 2019 | 44532 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2015 | 7993 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 894 | 0.110 |
Why?
|
| Tight Junction Proteins | 1 | 2012 | 14 | 0.110 |
Why?
|
| Endotoxemia | 1 | 2012 | 18 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 295 | 0.110 |
Why?
|
| Type C Phospholipases | 1 | 2011 | 28 | 0.100 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2011 | 15 | 0.100 |
Why?
|
| Xenopus laevis | 2 | 2011 | 137 | 0.100 |
Why?
|
| Survival Rate | 1 | 2015 | 1863 | 0.100 |
Why?
|
| Tight Junctions | 1 | 2012 | 149 | 0.100 |
Why?
|
| Models, Animal | 1 | 2012 | 263 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 3092 | 0.100 |
Why?
|
| Rats | 2 | 2017 | 3990 | 0.100 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2010 | 6 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1805 | 0.090 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2010 | 14 | 0.090 |
Why?
|
| Cell Nucleus | 2 | 2014 | 579 | 0.090 |
Why?
|
| Enzyme Activators | 1 | 2010 | 14 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 165 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 1219 | 0.090 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2010 | 36 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 68 | 0.090 |
Why?
|
| Biotinylation | 1 | 2010 | 41 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 74 | 0.090 |
Why?
|
| NFATC Transcription Factors | 2 | 2007 | 29 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 134 | 0.090 |
Why?
|
| Dynamins | 1 | 2010 | 49 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1801 | 0.090 |
Why?
|
| Protein Binding | 2 | 2016 | 1456 | 0.090 |
Why?
|
| Dogs | 1 | 2010 | 685 | 0.090 |
Why?
|
| Hormones | 1 | 2009 | 141 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2010 | 692 | 0.080 |
Why?
|
| Protein Transport | 1 | 2010 | 411 | 0.080 |
Why?
|
| Osmosis | 1 | 2008 | 6 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2009 | 209 | 0.080 |
Why?
|
| Transfection | 1 | 2010 | 896 | 0.080 |
Why?
|
| Absorption | 1 | 2007 | 25 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 75 | 0.080 |
Why?
|
| Models, Biological | 1 | 2015 | 1749 | 0.080 |
Why?
|
| Elementary Particles | 1 | 2007 | 11 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2015 | 2261 | 0.080 |
Why?
|
| Particle Accelerators | 1 | 2007 | 16 | 0.080 |
Why?
|
| Blood Urea Nitrogen | 1 | 2007 | 34 | 0.080 |
Why?
|
| Prognosis | 1 | 2015 | 3679 | 0.080 |
Why?
|
| Photons | 1 | 2007 | 46 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 416 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 712 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2008 | 281 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2008 | 270 | 0.070 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2007 | 79 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2022 | 480 | 0.070 |
Why?
|
| Massachusetts | 1 | 2016 | 33 | 0.070 |
Why?
|
| Religion | 1 | 2007 | 87 | 0.070 |
Why?
|
| Spirituality | 1 | 2007 | 87 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 214 | 0.070 |
Why?
|
| Colchicine | 1 | 2005 | 23 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 589 | 0.070 |
Why?
|
| G2 Phase | 1 | 2005 | 34 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2007 | 197 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2016 | 160 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2005 | 145 | 0.070 |
Why?
|
| Tubulin | 1 | 2005 | 58 | 0.070 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2005 | 67 | 0.070 |
Why?
|
| Microtubules | 1 | 2005 | 119 | 0.060 |
Why?
|
| Kidney Concentrating Ability | 1 | 2004 | 9 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2005 | 287 | 0.060 |
Why?
|
| Aged | 2 | 2015 | 18415 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2016 | 238 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 2062 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 567 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 425 | 0.060 |
Why?
|
| Cell Division | 1 | 2005 | 696 | 0.060 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2023 | 14 | 0.060 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 63 | 0.060 |
Why?
|
| Mice, Nude | 1 | 2005 | 790 | 0.060 |
Why?
|
| Comorbidity | 1 | 2007 | 943 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 3030 | 0.060 |
Why?
|
| Young Adult | 1 | 2015 | 5976 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 1047 | 0.060 |
Why?
|
| Cell Survival | 1 | 2005 | 969 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 388 | 0.050 |
Why?
|
| Nephrons | 1 | 2022 | 18 | 0.050 |
Why?
|
| Binding Sites | 1 | 2005 | 1098 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 2232 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 1135 | 0.050 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2022 | 11 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1961 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2022 | 256 | 0.050 |
Why?
|
| Hospitalization | 1 | 2016 | 849 | 0.050 |
Why?
|
| Glucose | 1 | 2023 | 638 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2023 | 673 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 2426 | 0.040 |
Why?
|
| Natriuresis | 1 | 2019 | 30 | 0.040 |
Why?
|
| Ethylenediamines | 1 | 2019 | 14 | 0.040 |
Why?
|
| Quality of Life | 1 | 2007 | 1585 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2005 | 736 | 0.040 |
Why?
|
| Apoptosis | 1 | 2005 | 1683 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2019 | 69 | 0.040 |
Why?
|
| Hydrochlorothiazide | 1 | 2019 | 76 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1208 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2014 | 1924 | 0.040 |
Why?
|
| Deoxycholic Acid | 1 | 2017 | 10 | 0.040 |
Why?
|
| Chloride Channels | 1 | 2017 | 42 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2017 | 74 | 0.040 |
Why?
|
| Kidney Cortex | 1 | 2016 | 33 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2017 | 164 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2016 | 55 | 0.040 |
Why?
|
| Chlorides | 1 | 2017 | 103 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 168 | 0.040 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2016 | 94 | 0.030 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2017 | 119 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 268 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 332 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 90 | 0.030 |
Why?
|
| Diet | 1 | 2019 | 443 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 268 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 273 | 0.030 |
Why?
|
| United States | 1 | 2007 | 6672 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 912 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 2360 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 133 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 236 | 0.030 |
Why?
|
| DNA Primers | 1 | 2014 | 543 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2016 | 8489 | 0.030 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2011 | 1 | 0.030 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2011 | 14 | 0.030 |
Why?
|
| Xenopus Proteins | 1 | 2011 | 34 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 1991 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 286 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 826 | 0.020 |
Why?
|
| Base Sequence | 1 | 2014 | 2330 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 504 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 615 | 0.020 |
Why?
|
| Nuclear Physics | 1 | 2007 | 17 | 0.020 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2007 | 43 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2007 | 181 | 0.020 |
Why?
|
| Aquaporin 2 | 1 | 2004 | 3 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 2004 | 21 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2004 | 52 | 0.020 |
Why?
|
| Aquaporins | 1 | 2004 | 14 | 0.020 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2004 | 23 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2007 | 482 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 166 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2007 | 1078 | 0.010 |
Why?
|
| Water | 1 | 2004 | 277 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1540 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 2378 | 0.010 |
Why?
|